这个疫苗研究了两年终于完成一期。 对所有冠状病毒有效。
Dr. Kayvon Modjarrad, director of Walter Reed's infectious diseases branch,
confirmed to Defense One that Phase 1 successfully finished earlier this
month testing against Omicron and other existing variants.
Phase 1 tested the vaccine on human subjects who had neither been vaccinated
nor previously infected with COVID. Next, the vaccine will need to be
tested on human subjects who have been vaccinated or previously tested
positive for the virus. http://www.dailymail.co.uk/news/article-10335105/Army-announce-developed-single-vaccine-protects-variants-COVID-SARS.html
